← All research articles
Longevity May 2026 5 min read

Epitalon: The Longevity Peptide with 30 Years of Russian Research Behind It

⚠️ For informational and educational purposes only. Not medical advice. All treatments require evaluation by a licensed physician. Do not self-administer any compound without medical supervision.
⚠️ For educational purposes only. This is not medical advice. Consult a licensed physician before considering any peptide therapy.

What Is Epitalon?

Epitalon (also written Epithalon) is a tetrapeptide — four amino acids: alanine, glutamic acid, aspartic acid, and glycine. It was developed at the St. Petersburg Institute of Bioregulation and Gerontology in Russia by Vladimir Khavinson, and represents over 30 years of focused research into what Khavinson’s group calls “peptide bioregulators” — short peptides that appear to regulate gene expression and slow certain aspects of biological aging.

Epitalon is a synthetic version of epithalamin, a natural extract derived from the pineal gland. The pineal gland regulates melatonin production and is deeply involved in circadian rhythm, sleep, and aspects of immune function. The research interest in Epitalon stems partly from this connection and partly from its reported effects on telomeres — the protective caps on your DNA.

The Telomere Story

Telomeres are sequences of DNA at the end of each chromosome, often compared to the plastic tips on shoelaces. Every time a cell divides, telomeres get slightly shorter. When they get too short, the cell can no longer divide — it becomes senescent (dormant and potentially inflammatory) or dies. Telomere shortening is one of the most studied mechanisms of biological aging.

Telomerase is the enzyme that rebuilds and maintains telomeres. It is highly active in embryonic cells, moderately active in stem cells, and largely inactive in most adult somatic cells — which is why aging happens.

A 2003 study published in Neuro Endocrinology Letters reported that Epitalon induced telomerase activity in human somatic cells in vitro — essentially switching on an enzyme that is normally dormant in adult cells. This finding attracted significant attention in the longevity research community and remains one of the most cited pieces of evidence for Epitalon’s potential.

Animal Longevity Studies

Beyond the telomere work, Khavinson’s group published a series of studies in rodents and primates showing that long-term Epitalon treatment was associated with extended lifespan, reduced tumor incidence, and improved immune function in aged animals. These studies are notable for their duration — some ran for the full lifespan of the animals — and for their consistency of findings across multiple species.

Important Caveats

The majority of Epitalon research originates from a single institution. Independent replication by research groups outside of Russia is limited. This does not invalidate the findings, but it does mean the evidence base is narrower than for some other compounds. Western regulatory bodies have not reviewed this research in the context of drug approval.

Human clinical data is sparse. Some small human studies from the same institution report positive outcomes, but these have not been replicated in large, independent, placebo-controlled trials.

Current Status

Epitalon is available through licensed 503A compounding pharmacies with a physician prescription. It is one of the compounds My Body Labs plans to include in the Longevity protocol.

Interested in physician-guided therapy?
Join our waitlist — launching July 2026
Founding member pricing · Personal onboarding call
Join waitlist →
« » ← All articles Have a question? →
For informational purposes only. My Body Labs is a telehealth technology platform. All treatments require evaluation and prescription from a licensed physician. Compounded medications are not FDA-approved finished products. Individual results vary. Not a substitute for professional medical advice.